Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Global AI is a biotechnology company that leverages advanced artificial intelligence and big data analytics to accelerate drug discovery and clinical development. The company's proprietary platform integrates diverse biological, chemical, and clinical datasets to identify novel therapeutic targets and optimize lead compounds across multiple therapeutic areas, including oncology and neurology. By utilizing machine learning algorithms, Global AI aims to reduce the time and cost associated with traditional drug development cycles. The company focuses on high-unmet-need indications and collaborates with pharmaceutical partners to advance its internal and partnered pipelines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Global AI.